Senior insider sale
Chief Executive Officer at TRAVERE THERAPEUTICS, INC. — senior position signals high conviction
$6.29M
95.67K shares
What this filing means
DUBE ERIC M plans to sell 95.67K shares of TRAVERE THERAPEUTICS, INC. valued at approximately $6.29M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/15/2026ACC: 0001950047-26-009513
DirectorOfficer· Chief Executive Officer
Since Jan 2019
95.67K
Shares to sell
$6.29M
Approx. market value
95.67K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
9/15/2026
95.67KTotal acquired95.67K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/15/2026 | Exercise of Stock Options Cash | 95.67K | — |
| Total | 95.67K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
95.67K
Market value
$6.29M
9/15/2026
Total
Units
95.67K
Value
$6.29M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
9/15/2026 | 95.67K | $6.29M | NASDAQ | Planned |
| Total | 95.67K | $6.29M | ||